143B | Osteosarcoma | Bone | Osteosarcoma
| 45 | 0.931 | 0.920 |
184B5 | Epithelial mammary gland cells | Breast | Normal
| 3 | 0.999 | 0.999 |
1A9 | Ovarian adenocarcinoma | Ovarium | Adenocarcinoma
| 93 | 0.991 | 0.990 |
1A9/ptx-10 | Ovarian adenocarcinoma | Ovarium | Adenocarcinoma
| 36 | 0.991 | 0.991 |
1A9/ptx-22 | Ovarian adenocarcinoma | Ovarium | Adenocarcinoma
| 24 | 0.995 | 0.994 |
2008 | Ovarian adenocarcinoma | Ovarium | Adenocarcinoma
| 4 | 0.863 | 0.866 |
4T1 | Epithelial mammary gland cells | Breast | Normal
| 37 | 0.887 | 0.885 |
518A2 | Melanoma | Derived from metastatic site: Not specified. | Melanoma
| 38 | 0.999 | 0.999 |
5637 | Urothelial bladder carcinoma | Urinary tract | Carcinoma
| 167 | 0.839 | 0.838 |
786-0 | Renal carcinoma | Kidney | Carcinoma
| 981 | 0.877 | 0.873 |
833K | Testicular embryonal carcinoma | Testicle | Carcinoma
| 16 | 0.992 | 0.993 |
8505C | Thyroid gland undifferentiated (anaplastic) carcinoma | Thyroid | Carcinoma
| 129 | 0.832 | 0.833 |
A172 | Glioblastoma | Brain | Glioblastoma
| 6 | 0.807 | 0.810 |
A-375 | Malignant melanoma | Skin | Melanoma
| 1407 | 0.931 | 0.930 |
A-427 | Lung carcinoma | Lung | Carcinoma
| 210 | 0.872 | 0.866 |
A-431 | Epidermoid carcinoma | Skin | Carcinoma
| 1547 | 0.937 | 0.935 |
A121 | Ovarian carcinoma | Ovarium | Carcinoma
| 80 | 1.000 | 1.000 |
A2058 | Melanoma | Skin | Melanoma
| 109 | 0.859 | 0.851 |
A2780 | Ovarian carcinoma | Ovarium | Carcinoma
| 2930 | 0.931 | 0.930 |
A2780/T | Putative Paclitaxel-resistant ovarian endometrioid adenocarcinoma | Ovarium | Adenocarcinoma
| 29 | 0.959 | 0.959 |
A2780S | Ovarian endometrioid adenocarcinoma | Ovarium | Adenocarcinoma
| 13 | 0.851 | 0.855 |
A2780cisR | Cisplatin-resistant ovarian carcinoma | Ovarium | Carcinoma
| 3 | 0.838 | 0.843 |
A498 | Renal carcinoma | Kidney | Carcinoma
| 1046 | 0.892 | 0.891 |
A549 | Lung carcinoma | Lung | Carcinoma
| 15040 | 0.856 | 0.856 |
A549/CDDP | Putative Taxol-resistant lung adenocarcinoma | Lung | Adenocarcinoma
| 23 | 0.999 | 0.999 |
A549/TR | Putative Cisplatin-resistant lung adenocarcinoma | Lung | Adenocarcinoma
| 26 | 0.959 | 0.959 |
ACHN | Papillary renal carcinoma | Kidney | Carcinoma
| 1582 | 0.901 | 0.899 |
ADR5000 | Childhood T acute lymphoblastic leukemia | Blood | Leukemia
| 11 | 0.911 | 0.913 |
AG1523 | Fibroblast | Fibroblast | Normal
| 25 | 0.962 | 0.961 |
AGS | Gastric adenocarcinoma | Stomach | Adenocarcinoma
| 310 | 0.875 | 0.872 |
ARPE-19 | Retinal pigmented epithelium | Eye; Retina | Normal
| 48 | 1.000 | 1.000 |
ASPC1 | Pancreatic ductal adenocarcinoma | Pancreas | Adenocarcinoma
| 234 | 0.901 | 0.894 |
ATH-8 | HTLV-I-infected human T-cell line | Peripheral blood | Normal
| 3 | 0.964 | 0.965 |
BE | Colon adenocarcinoma | Colon | Adenocarcinoma
| 17 | 0.988 | 0.988 |
BE-NQ | Colon adenocarcinoma | Colon | Adenocarcinoma
| 15 | 1.000 | 1.000 |
BEAS-2B | Epithelial cells | bronchial epithelium | Normal
| 9 | 1.000 | 0.999 |
BGC-823 | Stomach adenocarcinoma | Stomach | Adenocarcinoma
| 92 | 0.969 | 0.969 |
BHK-21 | Fibroblast | kidney | Normal
| 15 | 0.905 | 0.909 |
BJ | Foreskin fibroblast | Foreskin | Normal
| 150 | 0.955 | 0.955 |
BT-474 | Breast ductal carcinoma | Breast | Carcinoma
| 625 | 0.941 | 0.941 |
BT-549 | Breast ductal carcinoma | Breast | Carcinoma
| 839 | 0.882 | 0.880 |
BV-2 | Murine microglial cell line | Microglial cells | Normal
| 44 | 0.962 | 0.961 |
BXPC-3 | Pancreatic adenocarcinoma | Pancreas | Adenocarcinoma
| 485 | 0.917 | 0.916 |
Bcap37 | Breast adenocarcinoma | Breast | Adenocarcinoma
| 109 | 0.979 | 0.979 |
Bel-7402 | Hepatoma | Liver | Hepatoma
| 133 | 0.970 | 0.967 |
Bel7402/5-FU | Human papillomavirus-related endocervical adenocarcinoma | Uterus; Cervix | Adenocarcinoma
| 28 | 0.966 | 0.966 |
C180-13S | Ovarian carcinoma | Ovarium | Carcinoma
| 11 | 0.999 | 0.999 |
C6 | Glioma | Brain | Glioma
| 8 | 0.980 | 0.761 |
C8166 | Leukemic T-cells | Blood | Leukemia
| 105 | 0.839 | 0.841 |
CA46 | Burkitts Lymphoma | Blood | Lymphoma
| 98 | 0.810 | 0.813 |
CAKI-1 | Kidney carcinoma | Kidney | Carcinoma
| 979 | 0.880 | 0.877 |
CAKI-2 | Kidney carcinoma | Kidney | Carcinoma
| 5 | 0.829 | 0.834 |
CAL-27 | Squamous Cell Carcinoma | Tongue | Carcinoma
| 113 | 0.854 | 0.859 |
CAL-51 | Breast carcinoma | Breast | Carcinoma
| 117 | 0.824 | 0.821 |
CAPAN-1 | Pancreas Adenocarcinoma | Pancreas | Adenocarcinoma
| 149 | 0.889 | 0.892 |
CCD-18Co | Fibroblasts | Colon | Normal
| 261 | 0.994 | 0.994 |
CCRF-CEM | Childhood T acute lymphoblastic leukemia | Blood | Leukemia
| 3625 | 0.913 | 0.912 |
CCRF-CEM/VCR-1000 | T-cell leukaemia | Blood | Leukemia
| 62 | 0.989 | 0.990 |
CCRF-HSB-2 | Childhood T acute lymphoblastic leukemia | Blood | Leukemia
| 23 | 0.941 | 0.942 |
CCRF-SB | Childhood T acute lymphoblastic leukemia | Blood | Leukemia
| 91 | 0.967 | 0.967 |
CEM-DNR | Childhood T acute lymphoblastic leukemia | Blood | Leukemia
| 12 | 0.951 | 0.952 |
CEM-SS | Childhood T acute lymphoblastic leukemia | Blood | Leukemia
| 142 | 0.984 | 0.985 |
CEM-c113 | Childhood T acute lymphoblastic leukemia | Blood | Leukemia
| 4 | 1.000 | 1.000 |
CEM/C2 | Camptothecin-resistant CEM | Blood | Leukemia
| 17 | 0.934 | 0.937 |
CFPAC-1 | Pancreatic carcinoma | Pancreas | Carcinoma
| 84 | 0.905 | 0.906 |
CL1-0 | Lung adenocarcinoma | Lung | Adenocarcinoma
| 4 | 0.830 | 0.832 |
CL97 | Lung adenocarcinoma | Lung | Adenocarcinoma
| 6 | 0.872 | 0.880 |
CNE | Hybrid cell line | Hybrid | Normal
| 4 | 0.992 | 0.992 |
CNE-2 | Hybrid cell line | Hybrid | Normal
| 4 | 0.990 | 0.991 |
CNE2Z | Hybrid cell line | Hybrid | Normal
| 3 | 1.000 | 1.000 |
COLO-205 | Colorectal Adenocarcinoma | Colon | Adenocarcinoma
| 1700 | 0.901 | 0.899 |
COLO-320 | Colon adenocarcinoma | Colon | Adenocarcinoma
| 10 | 0.999 | 0.998 |
COLO-320DM | Colorectal Adenocarcinoma | Colon | Adenocarcinoma
| 64 | 0.994 | 0.980 |
COLO357 | Pancreatic adenosquamous carcinoma | Pancreas | Carcinoma
| 11 | 1.000 | 1.000 |
COR-L23 | Lung large cell carcinoma | Lung | Carcinoma
| 115 | 0.834 | 0.836 |
CPT30 | Nasopharyngeal carcinoma | Head and neck | Carcinoma
| 7 | 1.000 | 1.000 |
CRL-7065 | Fibroblast | Skin | Normal
| 9 | 0.934 | 0.935 |
CT26 | Mouse colon adenocarcinoma | Colon | Adenocarcinoma
| 15 | 0.869 | 0.871 |
CWR22R | Prostate carcinoma epithelial cell line | Prostate | Carcinoma
| 303 | 0.911 | 0.907 |
Cac-2 | Carcinoma Adenoide Cistico 2 | Adenoide | Carcinoma
| 345 | 0.925 | 0.922 |
Caco-2 | Colon adenocarcinoma | Colon | Adenocarcinoma
| 47 | 0.898 | 0.899 |
Calu-1 | Epidermoid Carcinoma | Lung | Carcinoma
| 85 | 0.851 | 0.853 |
Caov-3 | Ovary Adenocarcinoma | Ovary | Adenocarcinoma
| 7 | 0.890 | 0.892 |
Capan-2 | Pancreas Adenocarcinoma | Pancreas | Adenocarcinoma
| 13 | 0.895 | 0.893 |
Cav-3 | Transformed cell line | Kidney | Normal
| 57 | 0.936 | 0.939 |
Col2 | Colon carcinoma | Colon | Carcinoma
| 3 | 1.000 | 1.000 |
CuFi-1 | Cystic Fibrosis | Lung; Bronchus; Epithelium | Normal
| 3 | 1.000 | 1.000 |
D54 | Glioblastoma | Brain | Glioblastoma
| 4 | 0.995 | 0.995 |
DAN-G | Human pancreas adenocarcinoma cell line | Pancreas | Adenocarcinoma
| 54 | 0.962 | 0.955 |
DLD-1 | Colon adenocarcinoma | Colon | Adenocarcinoma
| 724 | 0.949 | 0.949 |
DMS-114 | Lung carcinoma | Lung | Carcinoma
| 124 | 0.834 | 0.837 |
DO4 | Melanoma | Skin | Melanoma
| 6 | 0.999 | 0.999 |
DU-145 | Prostate carcinoma | Prostate | Carcinoma
| 4562 | 0.896 | 0.896 |
DU-4475 | Breast Carcinoma | Breast | Carcinoma
| 125 | 0.802 | 0.800 |
Daoy | Desmoplastic Cerebellar Medulloblastoma | Brain | Medulloblastoma
| 21 | 0.908 | 0.909 |
Daudi | Burkitts Lymphoma | Blood | Lymphoma
| 31 | 0.990 | 0.990 |
Detroit562 | Pharyngeal Carcinoma | Pharynx | Carcinoma
| 5 | 0.989 | 0.989 |
EA.hy926 | Somatic cell hybrid | Hybrid | Normal
| 20 | 0.968 | 0.968 |
EBC-1 | Lung squamous cell carcinoma | Lung | Carcinoma
| 19 | 0.944 | 0.945 |
ECa-109 | Esophageal squamous cell carcinoma | Esophagus | Carcinoma
| 94 | 0.961 | 0.962 |
EJ | Endometrial adenocarcinoma | Endometrium | Adenocarcinoma
| 9 | 1.000 | 1.000 |
EKVX | Non-small cell lung carcinoma | Lung | Carcinoma
| 522 | 0.841 | 0.841 |
EOL1 | Chronic eosinophilic leukemia, not otherwise specified | Blood | Leukemia
| 167 | 0.861 | 0.859 |
FHC | Epithelial cell | Large intestine; Colon | Normal
| 10 | 0.820 | 0.821 |
FaDu | Hypopharyngeal squamous carcinoma | Upper aerodigestive tract | Carcinoma
| 254 | 0.902 | 0.901 |
G-361 | Melanoma | Skin | Melanoma
| 191 | 0.890 | 0.882 |
G55T2 | Anaplastic astrocytoma | Brain | Astrocytoma
| 11 | 1.000 | 1.000 |
GC3/Cl | Colorectal carcinoma | Colon | Carcinoma
| 5 | 1.000 | 1.000 |
GC3/M | Colorectal carcinoma | Colon | Carcinoma
| 12 | 1.000 | 1.000 |
GC3/MTK- | Colorectal carcinoma | Colon | Carcinoma
| 13 | 1.000 | 1.000 |
GES1 | Gastric epithelial cell line | Stomach | Normal
| 33 | 0.963 | 0.964 |
GHOSTCXCR4 | Osteosarcoma | Bone | Sarcoma
| 3 | 1.000 | 1.000 |
GIST430 | Gastrointestinal stromal tumor | Intestine | Carcinoma
| 5 | 0.820 | 0.823 |
GIST48 | Gastrointestinal stromal tumor | Intestine | Carcinoma
| 6 | 0.805 | 0.806 |
GIST882 | Gastrointestinal stromal tumor | Intestine | Carcinoma
| 6 | 0.824 | 0.828 |
GISTT1 | Gastrointestinal stromal tumor | Intestine | Carcinoma
| 32 | 0.942 | 0.941 |
GLC4 | Lung small cell carcinoma | Lung | Carcinoma
| 10 | 1.000 | 1.000 |
GM892A | Immortal human peripheral vein-derived B cell line cell | Blood | Normal
| 4 | 1.000 | 1.000 |
Granta-519 | Mantle cell lymphoma | Blood | Lymphoma
| 23 | 0.993 | 0.993 |
H2981 | Lung carcinoma | Lung | Carcinoma
| 11 | 0.989 | 0.989 |
H322 | Lung carcinoma | Lung | Carcinoma
| 6 | 1.000 | 1.000 |
H9 | T-lymphoid | Haematopoietic and lymphoid tissue | Leukemia
| 123 | 0.872 | 0.873 |
H9c2 | Rat DB1X heart myoblast cell line | Heart | Myoblast
| 9 | 0.897 | 0.787 |
HA22T | Hepatocellular carcinoma | Liver | Carcinoma
| 21 | 0.946 | 0.944 |
HBL | Melanoma | Skin | Melanoma
| 10 | 0.939 | 0.939 |
HBL-100 | Human mammary gland breast carcinoma | Breast | Carcinoma
| 21 | 0.957 | 0.957 |
HCC1806 | Acantholytic Squamous Cell Carcinoma | Breast | Carcinoma
| 108 | 0.824 | 0.820 |
HCC1937 | Breast Carcinoma | Breast | Carcinoma
| 78 | 0.806 | 0.791 |
HCC1954 | Breast Carcinoma | Breast | Carcinoma
| 94 | 0.829 | 0.830 |
HCC2998 | Colon adenocarcinoma | Colon | Adenocarcinoma
| 708 | 0.872 | 0.871 |
HCC78 | Lung adenocarcinoma | Lung | Adenocarcinoma
| 65 | 0.989 | 0.989 |
HCC827 | Lung Adenocarcinoma | Lung | Adenocarcinoma
| 113 | 0.985 | 0.985 |
HCT-116 | Colon carcinoma | Colon | Carcinoma
| 10992 | 0.890 | 0.889 |
HCT-116/VM46 | Colon carcinoma | Colon | Carcinoma
| 104 | 0.998 | 0.998 |
HCT-15 | Colon adenocarcinoma | Colon | Adenocarcinoma
| 2078 | 0.910 | 0.909 |
HCT-8 | Ileocecal adenocarcinoma | Large intestine | Adenocarcinoma
| 681 | 0.960 | 0.958 |
HEC-1B | Adenocarcinoma | Uterus Endometrium | Adenocarcinoma
| 11 | 1.000 | 1.000 |
HEK-293T | Renal epithelial line | Kidney | Normal
| 58 | 0.967 | 0.967 |
HEK293 | Embryonic kidney fibroblast | Kidney | Normal
| 1110 | 0.898 | 0.898 |
HEL | Erythroleukemia | Blood | Leukemia
| 302 | 0.903 | 0.900 |
HEL299 | Fibroblasts | Lung | Normal
| 4 | 0.899 | 0.904 |
HET-1A | Epithelial cell | Esophagus | Normal
| 4 | 0.998 | 0.998 |
HEY | Ovarian carcinoma | Ovarium | Carcinoma
| 34 | 0.967 | 0.968 |
HFF | Foreskin fibroblast | Skin | Normal
| 27 | 0.955 | 0.951 |
HFL1 | Human foetal lung fibroblast | Lung | Normal
| 309 | 0.996 | 0.996 |
HGC-27 | Gastric carcinoma | Stomach | Carcinoma
| 148 | 0.830 | 0.821 |
HK-2 | Papilloma | Kidney | Normal
| 10 | 0.879 | 0.881 |
HL-60 | Promyeloblast leukemia | Haematopoietic and lymphoid tissue | Leukemia
| 5486 | 0.881 | 0.880 |
HL-60(TB) | Adult acute myeloid leukemia | Blood | Leukemia
| 53 | 0.950 | 0.949 |
HMEC-1 | Dermal microvascular endothelial cell | Skin; Dermis; Endothelium | Normal
| 42 | 0.981 | 0.981 |
HN5 | Squamous cell carcinoma | Skin | Carcinoma
| 75 | 0.987 | 0.987 |
HONE1 | Nasopharyngeal carcinoma | Head and neck | Carcinoma
| 5 | 1.000 | 1.000 |
HOP-18 | Non-small cell lung carcinoma | Lung | Carcinoma
| 9 | 0.933 | 0.862 |
HOP-62 | Non-small cell lung carcinoma | Lung | Carcinoma
| 1318 | 0.898 | 0.897 |
HOP-92 | Non-small cell lung carcinoma | Lung | Carcinoma
| 679 | 0.862 | 0.856 |
HOS | Osteosarcoma | Bone | Sarcoma
| 161 | 0.863 | 0.852 |
HOS-TE85 | Osteosarcoma | Bone | Sarcoma
| 13 | 0.844 | 0.845 |
HPAC | Pancreatic adenocarcinoma | Pancreas | Adenocarcinoma
| 28 | 0.932 | 0.934 |
HRT-18 | Colon adenocarcinoma | Colon | Adenocarcinoma
| 4 | 1.000 | 1.000 |
HS27 | Fibroblast | Skin | Normal
| 41 | 0.970 | 0.968 |
HT | Lymphoma | Haematopoietic and lymphoid tissue | Leukemia
| 121 | 0.857 | 0.860 |
HT-1080 | Fibrosarcoma | Soft tissue | Sarcoma
| 534 | 0.918 | 0.916 |
HT-29 | Colon adenocarcinoma | Colon | Adenocarcinoma
| 7636 | 0.888 | 0.887 |
HT1197 | Carcinoma | Urinary bladder | Carcinoma
| 59 | 0.815 | 0.815 |
HUVEC | Umbilical vein endothelial cell | Endothelium | Normal
| 131 | 0.897 | 0.892 |
HaCaT | Keratinocyte | Skin | Normal
| 375 | 0.967 | 0.967 |
HeLa | Cervical adenocarcinoma | Cervix | Adenocarcinoma
| 8431 | 0.885 | 0.884 |
HeLaS3 | Adenocarcinoma | Uterus; Cervix | Adenocarcinoma
| 23 | 0.974 | 0.975 |
Hep3B2 | Childhood hepatocellular carcinoma | Liver | Carcinoma
| 135 | 0.957 | 0.956 |
Hep293TT | Hepatoblastoma | Liver | Hepatoblastoma
| 13 | 0.987 | 0.987 |
HepG2 | Hepatoblastoma | Liver | Hepatoblastoma
| 7802 | 0.873 | 0.871 |
HepG22.2.15 | Hepatoblastoma | Liver | Hepatoblastoma
| 12 | 0.853 | 0.854 |
HepG2-CD81 | Hepatoblastoma (HepG2) cells expressing CD81 | Liver | Hepatoblastoma
| 5768 | 0.932 | 0.932 |
Hs-578T | Invasive ductal breast carcinoma | Breast | Carcinoma
| 434 | 0.869 | 0.865 |
Hs683 | Glioma | Brain | Glioma
| 47 | 0.959 | 0.958 |
Hs766 | Pancreatic adenocarcinoma | Liver | Carcinoma
| 11 | 1.000 | 1.000 |
HuCC-A1 | Intrahepatic cholangiocarcinoma | Liver | Carcinoma
| 16 | 0.881 | 0.883 |
HuP-T3 | Pancreatic adenocarcinoma | Pancreas | Adenocarcinoma
| 62 | 0.868 | 0.867 |
HuT78 | T-lymphoma | Haematopoietic and lymphoid tissue | Leukemia
| 40 | 0.978 | 0.977 |
Huh-7 | Hepatocellular carcinoma | Liver | Carcinoma
| 555 | 0.920 | 0.919 |
IGROV-1 | Ovarian adenocarcinoma | Ovarium | Adenocarcinoma
| 1116 | 0.891 | 0.888 |
IMR-32 | Neuroblastoma | Nervous system | Neuroblastoma
| 188 | 0.951 | 0.952 |
IMR-90 | Embryonic lung fibroblast | Lung | Normal
| 18 | 0.879 | 0.869 |
Ishikawa | Uterine carcinoma | Uterus | Carcinoma
| 111 | 0.965 | 0.965 |
JAM | Ovarian cystadenocarcinoma | Ovarium | Adenocarcinoma
| 5 | 0.999 | 0.999 |
JJN-3 | Plasma cell myeloma | Bone Marrow | Myeloma
| 17 | 1.000 | 1.000 |
JY | EBV-positive lymphoblastoid B cell line | Blood | Normal
| 13 | 1.000 | 1.000 |
JeKo-1 | Lymphoma | Blood | Lymphoma
| 74 | 0.948 | 0.950 |
Jurkat | Acute leukemic T-cells | Blood | Leukemia
| 218 | 0.946 | 0.947 |
JurkatE6.1 | Acute T cell leukemia | Blood | Leukemia
| 5 | 1.000 | 1.000 |
K-562R | Blast phase chronic myelogenous leukemia, BCR-ABL1 positive | Haematopoietic and lymphoid tissue | Leukemia
| 14 | 0.869 | 0.870 |
K562 | Erythroleukemia | Haematopoietic and lymphoid tissue | Leukemia
| 6204 | 0.892 | 0.892 |
K562/Adr | Blast phase chronic myelogenous leukemia, BCR-ABL1 positive | Haematopoietic and lymphoid tissue | Leukemia
| 13 | 0.972 | 0.974 |
KARPAS-299 | Anaplastic large cell lymphoma | Haematopoietic and lymphoid tissue | Leukemia
| 291 | 0.939 | 0.940 |
KARPAS-422 | Diffuse large B-cell lymphoma germinal center B-cell type | Haematopoietic and lymphoid tissue | Leukemia
| 128 | 0.875 | 0.875 |
KB | Human papillomavirus-related squamous cell carcinoma | Uterus; cervix | Carcinoma
| 203 | 0.966 | 0.967 |
KB3-1 | Human papillomavirus-related endocervical adenocarcinoma | Uterus | Adenocarcinoma
| 22 | 0.960 | 0.962 |
KB/VJ300 | Human papillomavirus-related endocervical adenocarcinoma | Uterus | Adenocarcinoma
| 23 | 0.989 | 0.989 |
KBM5 | Chronic myelogenous leukemia, BCR-ABL1 positive | Blood | Leukemia
| 6 | 0.931 | 0.932 |
KETR3 | Renal carcinoma | Kidney | Carcinoma
| 43 | 0.981 | 0.980 |
KG-1 | Acute myelogenous leukemia | Blood | Leukemia
| 253 | 0.901 | 0.897 |
KG-1a | Acute myelogenous leukemia | Blood | Leukemia
| 17 | 0.999 | 0.999 |
KK-47 | Bladder carcinoma | Bladder | Carcinoma
| 3 | 0.887 | 0.889 |
KKLS | Gastric adenocarcinoma | Stomach | Adenocarcinoma
| 4 | 1.000 | 1.000 |
KM-20L2 | Colon adenocarcinoma | Colon | Adenocarcinoma
| 4 | 1.000 | 1.000 |
KM12 | Colon adenocarcinoma | Colon | Adenocarcinoma
| 1049 | 0.875 | 0.873 |
KM3/BTZ | Plasma cell myeloma | Bone Marrow | Myeloma
| 6 | 0.994 | 0.994 |
KMS-12-BM | Plasma cell myeloma | Bone Marrow | Myeloma
| 4 | 0.998 | 0.998 |
KOPTK1 | Childhood T acute lymphoblastic leukemia | Blood | Leukemia
| 5 | 0.808 | 0.809 |
KYSE-520 | Esophageal squamous cell carcinoma | Esophagus | Carcinoma
| 83 | 0.858 | 0.857 |
Kasumi-1 | Acute myeloblastic leukemia | Blood | Leukemia
| 116 | 0.816 | 0.806 |
L02 | Human papillomavirus-related endocervical adenocarcinoma | Uterus | Adenocarcinoma
| 193 | 0.933 | 0.934 |
L1210 | Lymphocytic Leukemia | Blood | Leukemia, Animal cells
| 183 | 0.984 | 0.984 |
L132 | Human papillomavirus-related endocervical adenocarcinoma | Uterus | Adenocarcinoma
| 4 | 1.000 | 1.000 |
L2987 | Lung adenocarcinoma | Lung | Adenocarcinoma
| 11 | 0.978 | 0.978 |
L3.6pl | Pancreatic adenosquamous carcinoma | Pancreas | Carcinoma
| 3 | 0.976 | 0.977 |
L5178Y | Lymphoma | Blood | Lymphoma, Animal cells
| 18 | 0.960 | 0.956 |
LAPC4 | Prostate carcinoma | Prostate | Carcinoma
| 16 | 1.000 | 1.000 |
LNCaP | Prostate carcinoma | Prostate | Carcinoma
| 1665 | 0.947 | 0.947 |
LNCaPC4-2 | Prostate carcinoma | Prostate | Carcinoma
| 4 | 0.996 | 0.997 |
LOXIMVI | Amelanotic melanoma | Skin | Melanoma
| 1010 | 0.877 | 0.876 |
LS174T | Colon adencocarcinoma | Colon | Adenocarcinoma
| 78 | 0.910 | 0.906 |
LXFL529 | Lung non-small cell carcinoma | Lung | Carcinoma
| 13 | 0.979 | 0.980 |
Leukemiacells | Leukemia | Blood | Leukemia
| 14 | 0.902 | 0.902 |
LoVo | Colon adenocarcinoma | Colon | Adenocarcinoma
| 71 | 0.911 | 0.914 |
Lu1 | Lung carcinoma | Lung | Carcinoma
| 20 | 0.995 | 0.995 |
M14 | Melanoma | Skin | Melanoma
| 1203 | 0.894 | 0.893 |
M19-MEL | Melanoma | Skin | Melanoma
| 9 | 0.925 | 0.866 |
M21 | Melanoma | Skin | Melanoma
| 280 | 0.985 | 0.985 |
M4Beu | Melanoma | Skin | Melanoma
| 6 | 1.000 | 1.000 |
MAXF401 | Breast carcinoma | Breast | Carcinoma
| 6 | 0.983 | 0.983 |
MCF-10A | Human mammary epithelial cell line | Breast | Normal
| 71 | 0.943 | 0.943 |
MCF-12A | Human mammary epithelial cell line | Breast | Normal
| 7 | 0.994 | 0.995 |
MCF7 | Breast carcinoma | Breast | Carcinoma
| 15718 | 0.836 | 0.836 |
MCF7R | Breast carcinoma | Breast | Carcinoma
| 72 | 0.996 | 0.996 |
MDA-MB-231 | Breast adenocarcinoma | Breast | Adenocarcinoma
| 7364 | 0.881 | 0.880 |
MDA-MB-361 | Breast adenocarcinoma | Breast | Adenocarcinoma
| 174 | 0.872 | 0.875 |
MDA-MB-435 | Amelanotic melanoma | Breast | Melanoma
| 101 | 0.947 | 0.944 |
MDA-MB-436 | Breast adenocarcinoma | Breast | Adenocarcinoma
| 29 | 0.933 | 0.934 |
MDA-MB-453 | Breast adenocarcinoma | Breast | Adenocarcinoma
| 233 | 0.888 | 0.886 |
MDA-MB-468 | Breast adenocarcinoma | Breast | Adenocarcinoma
| 1571 | 0.898 | 0.896 |
MEC1 | Chronic lymphocytic leukemia | Blood | Leukemia
| 14 | 0.997 | 0.997 |
MES-SA | Uterine corpus sarcoma | Uterus | Sarcoma
| 83 | 0.815 | 0.815 |
MES-SA/Dx5 | Uterine corpus sarcoma | Uterus | Sarcoma
| 46 | 0.940 | 0.940 |
MEXF276L | Xenograft melanoma | Skin | Melanoma
| 4 | 0.808 | 0.809 |
MGC-803 | Gastric mucinous adenocarcinoma | Stomach | Adenocarcinoma
| 214 | 0.959 | 0.959 |
MIAPaCa-2 | Pancreatic carcinoma | Pancreas | Carcinoma
| 854 | 0.919 | 0.918 |
MKN-28 | Gastric tubular adenocarcinoma | Stomach | Adenocarcinoma
| 17 | 0.919 | 0.920 |
MKN-45 | Gastric adenocarcinoma | Stomach | Adenocarcinoma
| 812 | 0.941 | 0.941 |
MKN-74 | Gastric tubular adenocarcinoma | Stomach | Adenocarcinoma
| 49 | 0.856 | 0.860 |
MM1.S | Immunoglobulin A Lambda Myeloma | Blood | Myeloma
| 204 | 0.988 | 0.988 |
MM96L | Melanoma | Skin | Melanoma
| 64 | 1.000 | 1.000 |
MOLM-13 | Adult acute myeloid leukemia | Blood | Leukemia
| 186 | 0.967 | 0.967 |
MOLM-14 | Adult acute myeloid leukemia | Blood | Leukemia
| 8 | 0.888 | 0.889 |
MOLT-3 | T-lymphoblastic leukemia | Blood | Leukemia
| 90 | 0.976 | 0.956 |
MOLT-4 | Acute T-lymphoblastic leukemia | Blood | Leukemia
| 1490 | 0.885 | 0.885 |
MONO-MAC-6 | Adult acute monocytic leukemia | Blood | Leukemia
| 92 | 0.807 | 0.810 |
MR49F | Prostate carcinoma | Prostate | Carcinoma
| 3 | 1.000 | 1.000 |
MRC5 | Embryonic lung fibroblast | Lung | Normal
| 596 | 0.916 | 0.916 |
MSTO-211H | Biphasic Mesothelioma | Lung | Mesothelioma
| 121 | 0.878 | 0.880 |
MT2 | Lymphocyte (HTLV-1 producing cell line) | Blood | Normal
| 101 | 0.963 | 0.963 |
MT4 | Adult T acute lymphoblastic leukemia | Blood | Leukemia
| 466 | 0.974 | 0.973 |
MV4-11 | Myeloid leukemia | Haematopoietic and lymphoid tissue | Leukemia
| 1832 | 0.947 | 0.947 |
MX1 | Breast carcinoma | Breast | Carcinoma
| 243 | 0.974 | 0.973 |
Mahlavu | Hepatocellular carcinoma | Liver | Carcinoma
| 3 | 0.937 | 0.938 |
Malme-3M | Melanoma | Skin | Melanoma
| 712 | 0.880 | 0.877 |
Maver1 | Mantle Cell Lymphoma | Blood | Lymphoma
| 31 | 0.930 | 0.931 |
NALM-6 | Adult B acute lymphoblastic leukemia | Haematopoietic and lymphoid tissue | Leukemia
| 192 | 0.849 | 0.850 |
NAMALVA | EBV-related Burkitt lymphoma | Blood | Lymphoma
| 35 | 0.986 | 0.986 |
NB-4 | Acute promyelocytic leukemia | Haematopoietic and lymphoid tissue | Leukemia
| 174 | 0.950 | 0.950 |
NCH82 | Glioblastoma | Brain | Glioblastoma
| 6 | 1.000 | 1.000 |
NCI-H128 | Small cell lung cancer | Lung | Carcinoma
| 16 | 0.908 | 0.914 |
NCI-H1299 | Non-small cell lung carcinoma | Lung | Carcinoma
| 470 | 0.916 | 0.914 |
NCI-H157 | Lung squamous cell carcinoma | Lung | Carcinoma
| 11 | 0.914 | 0.915 |
NCI-H1581 | Non Small Cell Lung Cancer | Lung | Carcinoma
| 146 | 0.871 | 0.865 |
NCI-H1650 | Bronchoalveolar carcinoma | Lung | Adenocarcinoma
| 139 | 0.839 | 0.837 |
NCI-H1703 | Non Small Cell Lung Cancer | Lung | Carcinoma
| 86 | 0.851 | 0.842 |
NCI-H187 | Small cell lung carcinoma | Lung | Carcinoma
| 88 | 0.846 | 0.845 |
NCI-H1975 | Bronchoalveolar carcinoma | Lung | Carcinoma
| 717 | 0.950 | 0.950 |
NCI-H1993 | Non-small cell lung cancer | Lung | Adenocarcinoma
| 146 | 0.913 | 0.914 |
NCI-H2171 | Small cell lung cancer | Lung | Carcinoma
| 299 | 0.953 | 0.953 |
NCI-H2228 | Non-small cell lung cancer | Lung | Adenocarcinoma
| 237 | 0.920 | 0.919 |
NCI-H226 | Non-small cell lung carcinoma | Lung | Carcinoma
| 868 | 0.880 | 0.878 |
NCI-H2286 | Small cell lung cancer | Lung | Adenocarcinoma
| 9 | 0.968 | 0.959 |
NCI-H23 | Non-small cell lung carcinoma | Lung | Carcinoma
| 1192 | 0.883 | 0.882 |
NCI-H292 | Mucoepidermoid Pulmonary Carcinoma | Lung | Carcinoma
| 142 | 0.845 | 0.847 |
NCI-H295R | Adrenal cortex carcinoma | Adrenal cortex | Carcinoma
| 11 | 0.856 | 0.860 |
NCI-H3122 | Bronchioalveolar Carcinoma | Lung; Bronchiole | Carcinoma
| 57 | 0.982 | 0.982 |
NCI-H322M | Non-small cell lung carcinoma | Lung | Carcinoma
| 634 | 0.881 | 0.881 |
NCI-H358 | Bronchioalveolar Carcinoma | Lung; Bronchiole | Carcinoma
| 109 | 0.805 | 0.782 |
NCI-H417 | Small cell lung carcinoma | Lung | Carcinoma
| 22 | 0.985 | 0.985 |
NCI-H441 | Papillary adenocarcinoma | Lung | Adenocarcinoma
| 69 | 0.813 | 0.802 |
NCI-H460 | Non-small cell lung carcinoma | Lung | Carcinoma
| 3810 | 0.906 | 0.904 |
NCI-H508 | Colorectal Adenocarcinoma | Large intestine; Cecum | Adenocarcinoma
| 10 | 0.991 | 0.991 |
NCI-H520 | Squamous Cell Carcinoma | Lung | Carcinoma
| 112 | 0.837 | 0.840 |
NCI-H522 | Non-small cell lung carcinoma | Lung | Carcinoma
| 1035 | 0.877 | 0.877 |
NCI-H647 | Adenosquamous lung carcinoma | Lung | Carcinoma
| 10 | 0.889 | 0.890 |
NCI-H661 | Lung carcinoma | Lung | Carcinoma
| 120 | 0.831 | 0.823 |
NCI-H69 | Small cell lung carcinoma | Lung | Carcinoma
| 205 | 0.902 | 0.904 |
NCI-H727 | Carcinoid | Lung; Bronchus | Carcinoma
| 107 | 0.828 | 0.812 |
NCI-H929 | Plasma cell myeloma | Bone Marrow | Myeloma
| 35 | 0.972 | 0.974 |
NCI-N87 | Gastric carcinoma | Stomach | Carcinoma
| 320 | 0.923 | 0.922 |
NCI/ADR-RES | High grade ovarian serous adenocarcinoma | Ovarium | Adenocarcinoma
| 98 | 0.914 | 0.911 |
NHDF | Fibroblast | Skin | Normal
| 30 | 0.953 | 0.955 |
NSCLC | Non-small cell lung carcinoma | Lung | Carcinoma
| 22 | 0.957 | 0.950 |
NT2 | Embryonal carcinoma | Germ cell. fibroblast | Carcinoma
| 58 | 0.993 | 0.993 |
NUGC-3 | Gastric carcinoma | Stomach | Carcinoma
| 288 | 0.926 | 0.927 |
OCI-AML-3 | Adult acute myeloid leukemia | Blood | Leukemia
| 14 | 0.982 | 0.982 |
OCI-AML2 | Adult acute myeloid leukemia | Blood | Leukemia
| 114 | 0.803 | 0.798 |
OCI-Ly1 | Diffuse large B-cell lymphoma | Lymphoid tissue | Lymphoma
| 5 | 1.000 | 1.000 |
OCI-Ly10 | Diffuse large B-cell lymphoma activated B-cell type | Lymphoid tissue | Lymphoma
| 3 | 0.919 | 0.922 |
OCI-Ly3 | Diffuse large B-cell lymphoma activated B-cell type | Lymphoid tissue | Lymphoma
| 40 | 0.986 | 0.986 |
OE33 | Barrett adenocarcinoma | Esophagus | Adenocarcinoma
| 56 | 0.805 | 0.802 |
OPM-2 | Plasma cell myeloma | Bone Marrow | Myeloma
| 81 | 0.823 | 0.829 |
OS-RC-2 | Clear cell renal cell carcinoma | Kidney | Carcinoma
| 117 | 0.812 | 0.808 |
OVCAR-3 | Ovarian adenocarcinoma | Ovarium | Adenocarcinoma
| 1728 | 0.907 | 0.907 |
OVCAR-4 | Ovarian adenocarcinoma | Ovarium | Adenocarcinoma
| 715 | 0.859 | 0.854 |
OVCAR-5 | Ovarian adenocarcinoma | Ovarium | Adenocarcinoma
| 617 | 0.866 | 0.863 |
OVCAR-8 | Ovarian adenocarcinoma | Ovarium | Adenocarcinoma
| 973 | 0.885 | 0.883 |
OVXF1023 | Ovarian adenocarcinoma | Ovarium | Adenocarcinoma
| 3 | 1.000 | 1.000 |
OVXF1353 | Ovarian adenocarcinoma | Ovarium | Adenocarcinoma
| 3 | 1.000 | 1.000 |
PA-1 | Ovarian carcinoma | Ovarium | Carcinoma
| 159 | 0.854 | 0.843 |
PANC-1 | Pancreatic carcinoma | Pancreas | Carcinoma
| 728 | 0.933 | 0.933 |
PBMC | Peripheral blood mononuclear cell | Blood | Normal
| 69 | 0.932 | 0.934 |
PC-12 | Rat adrenal gland pheochromocytoma | Adrenal gland | Carcinoma
| 21 | 0.943 | 0.943 |
PC-14 | Lung adenocarcinoma | Lung | Carcinoma
| 252 | 0.932 | 0.928 |
PC-3 | Prostate carcinoma | Prostate | Carcinoma
| 5760 | 0.883 | 0.882 |
PC-3M | Prostate carcinoma | Prostate | Carcinoma
| 7 | 0.870 | 0.871 |
PC-9 | Lung adenocarcinoma | Lung | Adenocarcinoma
| 130 | 0.951 | 0.952 |
PLC-PRF-5 | Adult hepatocellular carcinoma | Liver | Carcinoma
| 50 | 0.827 | 0.830 |
PNT1A | Human prostate epithelium cell line | Prostate | Normal
| 8 | 0.881 | 0.881 |
PT-45 | Pancreatic carcinoma | Pancreas | Carcinoma
| 20 | 0.938 | 0.939 |
Panc203 | Pancreatic carcinoma | Pancreas | Carcinoma
| 6 | 1.000 | 1.000 |
Panc430 | Pancreatic carcinoma | Pancreas | Carcinoma
| 8 | 1.000 | 1.000 |
Pfeiffer | Diffuse Large Cell Lymphoma | Blood | Lymphoma
| 35 | 0.993 | 0.993 |
QG-56 | Squamous cell lung carcinoma | Lung | Carcinoma
| 90 | 1.000 | 1.000 |
QGY-7703 | Hepatocellular carcinoma | Liver | Carcinoma
| 48 | 0.976 | 0.976 |
RCC4 | Clear cell renal cell carcinoma | Kidney | Carcinoma
| 3 | 0.845 | 0.848 |
RD | Rhabdomyosarcoma | Muscle | Normal
| 104 | 0.828 | 0.832 |
RKO | Colon carcinoma | Colon | Carcinoma
| 343 | 0.879 | 0.877 |
RL | Non-Hodgkin's Lymphoma | Ascites | Lymphoma
| 43 | 0.833 | 0.836 |
RPMI-7951 | Malignant Melanoma | Skin | Melanoma
| 130 | 0.854 | 0.847 |
RPMI-8226 | Multiple myeloma | Haematopoietic and lymphoid tissue | Myeloma
| 1013 | 0.883 | 0.881 |
RS4-11 | Adult B acute lymphoblastic leukemia | Bone Marrow | Leukemia
| 198 | 0.835 | 0.831 |
RWLeu4 | Chronic myelogenous leukemia | Blood | Leukemia
| 9 | 1.000 | 1.000 |
RWPE-1 | Prostatic epithelial cell line | Prostate | Normal
| 28 | 0.922 | 0.924 |
RXF393 | Renal cell carcinoma | Kidney | Carcinoma
| 795 | 0.873 | 0.869 |
RXF944 | Renal cell carcinoma | Kidney | Carcinoma
| 8 | 0.989 | 0.989 |
Raji | B-lymphoblastic cells | Haematopoietic and lymphoid tissue | Leukemia
| 430 | 0.938 | 0.938 |
Ramos | Burkitts lymhoma B-cells | Blood | Leukemia
| 189 | 0.958 | 0.959 |
Rec1 | Lymphoma; Mantle Cell | Lymph node | Lymphoma
| 22 | 1.000 | 1.000 |
S1B1-20 | Colon carcinoma | Colon | Carcinoma
| 38 | 1.000 | 1.000 |
SEM | Childhood B acute lymphoblastic leukemia | Blood | Leukemia
| 21 | 0.999 | 0.999 |
SF-268 | Glioblastoma | Brain | Glioblastoma
| 1287 | 0.890 | 0.889 |
SF-295 | Glioblastoma | Brain | Glioblastoma
| 1016 | 0.884 | 0.882 |
SF-539 | Glioblastoma | Brain | Glioblastoma
| 1104 | 0.888 | 0.888 |
SGC-7901 | Gastric carcinoma | Stomach | Carcinoma
| 128 | 0.963 | 0.963 |
SH-SY5Y | Bone marrow neuroblastoma | Brain | Neuroblastoma
| 380 | 0.930 | 0.926 |
SISO | Uterine cervical adenocarcinoma | Cervix | Adenocarcinoma
| 28 | 0.950 | 0.950 |
SJSA-1 | Osteosarcoma | Bone | Sarcoma
| 398 | 0.940 | 0.940 |
SK-BR-3 | Breast adenocarcinoma | Breast | Adenocarcinoma
| 1479 | 0.950 | 0.949 |
SK-HEP1 | Hepatocellular carcinoma | Liver | Carcinoma
| 234 | 0.912 | 0.911 |
SK-LU-1 | Adenocarcinoma | Lung | Carcinoma
| 80 | 0.810 | 0.806 |
SK-MEL-1 | Metastatic melanoma | Skin | Melanoma
| 64 | 0.808 | 0.808 |
SK-MEL-103 | Melanoma | Skin | Melanoma
| 3 | 0.999 | 0.999 |
SK-MEL-2 | Melanoma | Skin | Melanoma
| 1048 | 0.885 | 0.885 |
SK-MEL-28 | Melanoma | Skin | Melanoma
| 1160 | 0.879 | 0.879 |
SK-MEL-5 | Melanoma | Skin | Melanoma
| 1037 | 0.903 | 0.902 |
SK-MES-1 | Squamous cell lung carcinoma | Lung | Carcinoma
| 127 | 0.834 | 0.831 |
SK-N-SH | Neuroblastoma | Nervous system | Neuroblastoma
| 213 | 0.950 | 0.950 |
SK-OV-3 | Ovarian carcinoma | Ovarium | Carcinoma
| 2424 | 0.896 | 0.894 |
SKM-1 | Adult acute myeloid leukemia | Blood | Leukemia
| 66 | 0.917 | 0.918 |
SKW6.4 | Blastoid B-Cell | Lymphocytes | Normal
| 40 | 1.000 | 1.000 |
SMMC-7721 | Hepatocellular carcinoma | Liver | Carcinoma
| 298 | 0.959 | 0.956 |
SN12C | Renal carcinoma | Kidney | Carcinoma
| 1176 | 0.896 | 0.895 |
SNB-19 | Astrocytoma | Brain | Astrocytoma
| 76 | 0.948 | 0.949 |
SNB-7 | Glioblastoma | Brain | Glioblastoma
| 4 | 0.999 | 0.999 |
SNB-75 | Glioblastoma | Nervous system | Glioblastoma
| 871 | 0.877 | 0.874 |
SNU-16 | Gastric Carcinoma | Stomach | Carcinoma
| 65 | 0.850 | 0.847 |
SNU-398 | Hepatocellular carcinoma | Liver | Carcinoma
| 74 | 0.970 | 0.970 |
SNU-475 | Hepatocellular carcinoma | Liver | Carcinoma
| 22 | 0.819 | 0.814 |
SNU-5 | Gastric Carcinoma | Stomach | Carcinoma
| 97 | 0.828 | 0.831 |
SNU-638 | Gastric carcinoma | Stomach | Carcinoma
| 170 | 0.969 | 0.959 |
SPC-A4 | Lung Adenocarcinoma | Lung | Adenocarcinoma
| 10 | 1.000 | 1.000 |
SQ20B | Head and neck Squamous carcinoma | Head and neck | Carcinoma
| 33 | 0.958 | 0.960 |
SR | Adult immunoblastic lymphoma | Haematopoietic and lymphoid tissue | Lymphoma
| 944 | 0.877 | 0.875 |
SU-DHL-6 | Large Cell Lymphoma | Peritoneal effusion | Lymphoma
| 71 | 0.986 | 0.986 |
SU-DHL-8 | Large Cell Lymphoma | Lymph node | Lymphoma
| 4 | 0.847 | 0.850 |
SUD4 | Diffuse large B-cell lymphoma germinal center B-cell type | Lymphocytes | Lymphoma
| 14 | 0.811 | 0.814 |
SUM-159-PT | Breast pleomorphic carcinoma | Breast | Carcinoma
| 31 | 0.982 | 0.981 |
SUM149PT | Breast inflammatory carcinoma | Breast | Carcinoma
| 3 | 0.983 | 0.984 |
SUM185PE | Breast ductal carcinoma | Breast | Carcinoma
| 11 | 0.957 | 0.957 |
SUNE1 | Nasopharyngeal carcinoma | Nasopharynx | Carcinoma
| 3 | 1.000 | 1.000 |
SW-1736 | Thyroid gland undifferentiated (anaplastic) carcinoma | Thyroid | Carcinoma
| 80 | 0.987 | 0.987 |
SW-620 | Colon adenocarcinoma | Colon | Adenocarcinoma
| 1845 | 0.887 | 0.887 |
SW1116 | Colorectal Adenocarcinoma | Colon | Adenocarcinoma
| 46 | 0.864 | 0.867 |
SW1353 | Bone chondrosarcoma | Bone | Sarcoma
| 41 | 0.938 | 0.938 |
SW1573 | Lung carcinoma | Lung | Carcinoma
| 228 | 0.919 | 0.917 |
SW1990 | Pancreatic adenocarcinoma | Pancreas | Adenocarcinoma
| 108 | 0.876 | 0.875 |
SW48 | Colorectal Adenocarcinoma | Colon | Adenocarcinoma
| 101 | 0.806 | 0.809 |
SW480 | Colon adenocarcinoma | Colon | Adenocarcinoma
| 846 | 0.932 | 0.932 |
SiHa | Cervical squamous cell carcinoma | Cervix | Carcinoma
| 28 | 0.859 | 0.851 |
Sku1B | Rb positve uterine leiomyosarcoma | Uterus | Sarcoma
| 6 | 1.000 | 1.000 |
T-24 | Bladder carcinoma | Urinary tract | Carcinoma
| 297 | 0.925 | 0.923 |
T47D | Breast carcinoma | Breast | Carcinoma
| 461 | 0.936 | 0.934 |
T98 | Glioblastoma | Brain | Blastoma
| 5 | 1.000 | 1.000 |
T98G | Glioblastoma | Brain | Carcinoma
| 21 | 0.912 | 0.912 |
TERT-RPE1 | Retinal pigmented epithelial cell | Retina | Normal
| 31 | 0.942 | 0.942 |
TF-1 | Bone marrow erythroleukemic | Haematopoietic and lymphoid tissue | Leukemia
| 34 | 0.972 | 0.972 |
THP-1 | Acute monocytic leukemia | Blood | Leukemia
| 1482 | 0.937 | 0.934 |
TK-10 | Renal carcinoma | Kidney | Carcinoma
| 731 | 0.854 | 0.851 |
TMD8 | Diffuse large B-cell lymphoma activated B-cell type | Lymphocytes | Lymphoma
| 7 | 0.811 | 0.816 |
TOV112D | Ovarian endometrioid adenocarcinoma | Ovary | Carcinoma
| 4 | 0.998 | 0.998 |
TSGH9201 | Gastric signet ring cell adenocarcinoma | Stomach | Carcinoma
| 18 | 1.000 | 1.000 |
TSU | Prostatic carcinoma | Prostate | Carcinoma
| 15 | 0.947 | 0.948 |
U-251 | Astrocytoma | Brain | Astrocytoma
| 1478 | 0.883 | 0.882 |
U-266 | Plasma cell myeloma | Blood | Myeloma
| 147 | 0.870 | 0.864 |
U-87MG | Glioblastoma | Brain | Blastoma
| 622 | 0.921 | 0.919 |
U-937 | Histiocytic lymphoma | Haematopoietic and lymphoid tissue | Lymphoma
| 138 | 0.926 | 0.920 |
U-937/GTB | Histiocytic lymphoma | Blood | Lymphoma
| 10 | 0.846 | 0.852 |
U2OS | Osteosarcoma | Bone | Sarcoma
| 299 | 0.885 | 0.883 |
UACC-257 | Melanoma | Skin | Melanoma
| 571 | 0.861 | 0.858 |
UACC-375 | Melanoma | Skin | Melanoma
| 86 | 0.994 | 0.994 |
UACC-62 | Melanoma | Skin | Melanoma
| 1217 | 0.904 | 0.902 |
UACC-903 | Malignant melanoma | Skin | Melanoma
| 38 | 0.954 | 0.953 |
UCLAP-3 | Lung squamous cell carcinoma | Lung | Carcinoma
| 5 | 1.000 | 1.000 |
UMSCC22B | Hypopharyngeal squamous cell carcinoma | Upper aerodigestive tract | Carcinoma
| 4 | 1.000 | 1.000 |
UMUC3 | Bladder Carcinoma | Urinary tract | Carcinoma
| 86 | 0.810 | 0.806 |
UO-31 | Renal carcinoma | Kidney | Carcinoma
| 745 | 0.879 | 0.879 |
VCaP | Prostate carcinoma | Prostate | Carcinoma
| 86 | 0.980 | 0.980 |
WI-38 | Embryonic lung fibroblast | Lung | Normal
| 288 | 0.943 | 0.941 |
WIL2 | Lymphoblastoid cell | Haematopoietic, lymphoid tissue | Normal
| 39 | 1.000 | 1.000 |
WIL2-NS | Lymphoblastoid cell | Haematopoietic, lymphoid tissue | Normal
| 49 | 0.979 | 0.979 |
WM266-4 | Melanoma | skin | Melanoma
| 17 | 0.977 | 0.977 |
WM164 | Cutaneous melanoma | skin | Melanoma
| 18 | 0.964 | 0.964 |
WiDr | Adenocarcinoma; Colorectal | Colon | Carcinoma
| 23 | 0.893 | 0.896 |
XF498 | Glioma | Brain | Glioma
| 98 | 0.965 | 0.964 |
Y79 | Retinoblastoma | Eye; Retina | Blastoma
| 14 | 0.963 | 0.964 |
YAPC | Pancreatic carcinoma | Pancreas | Carcinoma
| 50 | 0.817 | 0.810 |
Z-138 | Lymphoma; Mantle Cell | lymph nodes | Lymphoma
| 51 | 0.925 | 0.922 |
ZR-75-1 | Breast carcinoma | Breast | Carcinoma
| 242 | 0.965 | 0.966 |